- Home
- SHC
SHC
Sotera Health Company
as 04-01-2025 4:00pm EST
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | BROADVIEW HEIGHTS |
| Market Cap: | N/A | IPO Year: | 2020 |
| Target Price: | $16.50 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.16 | EPS Growth: | -12.89 |
| 52 Week Low/High: | $10.71 - $17.08 | Next Earning Date: | 05-01-2025 |
| Revenue: | $1,100,441,000 | Revenue Growth: | 4.88% |
| Revenue Growth (this year): | 4.14% | Revenue Growth (next year): | 6.11% |
Latest Sotera Health Company News
SHC Breaking Stock News: Dive into SHC Ticker-Specific Updates for Smart Investing
StockStory
5 days ago
Research Tools & Consumables Stocks Q4 Earnings: Bio-Techne (NASDAQ:TECH) Best of the Bunch
Argus Research
7 days ago
SHC: What does Argus have to say about SHC?
Zacks
21 days ago
Strength Seen in Elevance Health (ELV): Can Its 3.1% Jump Turn into More Strength?
StockStory
21 days ago
Q4 Earnings Highlights: Sotera Health Company (NASDAQ:SHC) Vs The Rest Of The Research Tools & Consumables Stocks
Simply Wall St.
a month ago
Sotera Health's (NASDAQ:SHC) Conservative Accounting Might Explain Soft Earnings
Argus Research
a month ago
SHC: Lowering target price to $9.00
GlobeNewswire
a month ago
Nelson Labs Launches Innovative Rapid Sterility Testing to Significantly Expedite Product Sterility Results
Simply Wall St.
a month ago
Sotera Health Full Year 2024 Earnings: EPS Misses Expectations
Compare SHC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SHC Sotera Health Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.